References
- Ostrosky-ZeichnerLPappasPGInvasive candidiasis in the intensive care unitCrit Care Med200634385786316505666
- KettDHAzoulayEEcheverriaPMVincentJLExtended Prevalence of Infection in ICU Study (EPIC II) Group of InvestigatorsCandida bloodstream infections in intensive care units: analysis of the extended prevalence of infection in intensive care unit studyCrit Care Med201139466567021169817
- LipsettPASurgical critical care: fungal infections in surgical patientsCrit Care Med34Suppl 9S215S22416917426
- FlanaganPGBarnesRAFungal infection in the intensive care unitJ Hosp Infect19983831631779561467
- Alvarez-LermaFNolla-SalasJLeónCEPCAN Study GroupCandiduria in critically ill patients admitted to intensive care medical unitsIntensive Care Med20032971069107612756441
- Borg-von ZepelinMKunzLRüchelRReichardUWeigMGrossUEpidemiology and antifungal susceptibilities of Candida spp. to six antifungal agents: results from a surveillance study on fungaemia in Germany from July 2004 to August 2005J Antimicrob Chemother200760242442817562683
- PfallerMADiekemaDJEpidemiology of invasive candidiasis: a persistent public health problemClin Microbiol Rev200720113316317223626
- BassettiMRighiECostaAEpidemiological trends in nosoco-mial candidemia in intensive careBMC Infect Dis200662116472387
- LeroyOGangneuxJPMontraversPAmarCand Study GroupEpidemiology, management, and risk factors for death of invasive Candida infections in critical care: a multicenter, prospective, observational study in France (2005–2006)Crit Care Med20093751612161819325476
- TortoranoAMCaspaniLRigoniALBiraghiESicignanoAVivianiMACandidosis in the intensive care unit: a 20-year surveyJ Hosp Infect200457181315142710
- GareyKWRegeMPaiMPTime to initiation of fluconazole therapy impacts mortality in patients with candidemia: a multi-institutional studyClin Infect Dis2006431253116758414
- CharlierCHartELefortAFluconazole for the management of invasive candidiasis: where do we stand after 15 years?J Antimicrob Chemother200657338441016449304
- LichtensternCGeissHKBöttingerBWWeigandMAAntimykotische Therapie in der Intensivmedizin [Antimycotic therapy in the intensive care unit]Intensivmed.up2date200732140 German
- UllmannAJSanzMATramarinALongitudinal Evaluation of Antifungal Drugs (LEAD I) InvestigatorsProspective study of ampho-tericin B formulations in immunocompromised patients in 4 European countriesClin Infect Dis2006434e29e3816838223
- FischerMAWinkelmayerWCRubinRHAvornJThe hepatotoxicity of antifungal medications in bone marrow transplant recipientsClin Infect Dis200541330130716007524
- KauffmanCACarverPLUse of azoles for systemic antifungal therapyAdv Pharmacol1997391431899160115
- EggimannPFrancioliPBilleJFluconazole prophylaxis prevents intra-abdominal candidiasis in high-risk surgical patientsCrit Care Med19992761066107210397206
- GarbinoJLewDPRomandJAHugonnetSAuckenthalerRPittetDPrevention of severe Candida infections in nonneutropenic, high-risk, critically ill patients: a randomized, double-blind, placebo-controlled trial in patients treated by selective digestive decontaminationIntensive Care Med200228121708171712447512
- PelzRKHendrixCWSwobodaSMDouble-blind placebo-controlled trial of fluconazole to prevent candidal infections in critically ill surgical patientsAnn Surg2001233454254811303137
- SchusterMGEdwardsJEJrSobelJDEmpirical fluconazole versus placebo for intensive care unit patients: a randomized trialAnn Intern Med20081492839018626047
- RexJHPappasPGKarchmerAWNational Institute of Allergy and Infectious Diseases Mycoses Study GroupA randomized and blinded multicenter trial of high-dose fluconazole plus placebo versus fluconazole plus amphotericin B as therapy for candidemia and its consequences in nonneutropenic subjectsClin Infect Dis200336101221122812746765
- MontraversPJabbourKClinical consequences of resistant Candida infections in intensive careInt J Antimicrob Agents20062711616343859
- World Medical Association (WMA)WMA Declaration of Helsinki: Ethical Principles for Medical Research Involving Human SubjectsFerney-VoltaireWMA2008 Available from: http://www.wma.net/en/30publications/10policies/b3/17c.pdfAccessed December 2, 2012
- International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH)Guideline for Good Clinical Practice. E6(R1). June 10GenevaICH1996 Available from: http://private.ich.org/LOB/media/MEDIA482.pdfAccessed December 2, 2012
- VazquezJASanchezVDmuchowskiCDembryLMSobelJDZervosMJNosocomial acquisition of Candida albicans: an epidemiologic studyJ Infect Dis199316811952018515108
- BorzottaAPBeardsleyKCandida infections in critically ill trauma patients: a retrospective case-control studyArch Surg1999134665766510367877
- De WaeleJJVogelaersDBlotSColardynFFungal infections in patients with severe acute pancreatitis and the use of prophylactic therapyClin Infect Dis200337220821312856213
- RichardsMJEdwardsJRCulverDHGaynesRPNosocomial infections in medical intensive care units in the United States. National Nosocomial Infections Surveillance SystemCrit Care Med199927588789210362409
- VincentJLAnaissieEBruiningHEpidemiology, diagnosis and treatment of systemic Candida infection in surgical patients under intensive careIntensive Care Med19982432062169565801
- Nolla-SalasJSitges-SerraALeón-GilCCandidemia in non-neutropenic critically ill patients: analysis of prognostic factors and assessment of systemic antifungal therapy. Study Group of Fungal Infection in the ICUIntensive Care Med199723123309037636
- ShorrAFChungKJacksonWLWatermanPEKollefMHFluconazole prophylaxis in critically ill surgical patients: a meta-analysisCrit Care Med20053391928193516148461
- MeerssemanWVan WijngaerdenEInvasive aspergillosis in the ICU: an emerging diseaseIntensive Care Med200733101679168117646965
- SobelJDRexJHInvasive candidiasis: turning risk into a practical prevention policy?Clin Infect Dis20013318718910.1086/32181211418878
- PappasPGKauffmanCAAndesDInfectious Diseases Society of AmericaClinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of AmericaClin Infect Dis200948550353519191635
- DenningDWManagement of deep Candida infection in surgical and intensive care unit patientsIntensive Care Med19942075225287995872
- CornelyOABassettiMCalandraTESCMID Fungal Infection Study GroupESCMID guideline for the diagnosis and management of Candida diseases 2012: non-neutropenic adult patientsClin Microbiol Infect201218Suppl 7193723137135
- KullbergBJOude LashofAMEpidemiology of opportunistic invasive mycosesEur J Med Res20027518319112069910
- PappasPGRexJHLeeJNIAID Mycoses Study GroupA prospective observational study of candidemia: epidemiology, therapy, and influences on mortality in hospitalized adult and pediatric patientsClin Infect Dis200337563464312942393
- PfallerMAJonesRNDoernGVInternational surveillance of blood stream infections due to Candida species in the European SENTRY Program: species distribution and antifungal susceptibility including the investigational triazole and echinocandin agents. SENTRY Participant Group (Europe)Diagn Microbiol Infect Dis1999351192510529877
- Garnacho-MonteroJDíaz-MartínAGarcía-CabreraERisk factors for fluconazole-resistant candidemiaAntimicrob Agents Chemother20105483149315420498325
- KamLWLinJDManagement of systemic candidal infections in the intensive care unitAm Syst Health Care Pharm20025913341